Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Migraine
Prophylactic Dotarizine Helps Reduce Headaches
March 31st, 2000
Prophylactic oral therapy with dotarizine reduces frequency and duration of migraine headaches. In a paper presented at the 2000 Annual Meeting of American Society for Clinical Pharmacology and Therapeutics, held March 14-18, 2000, in Los Angeles, California, S. Diamond, MD, and colleagues from the Diamond Headache Clinic, and six other headache clinics in the United States reported on their evaluation of the efficacy and safety of dotarizine (DTZ) as a prophylactic therapy for migraine headaches. The prospective study titled "Dotarizine in the prophylaxis of migraine headaches," was conducted in multicenter parallel groups. A one-month observation...
Source: Drug Week (2000-03-31)
|
